AdvaMed, Dems, Public Citizen Share Opposition To Proposed Labeling Rule

AdvaMed is siding with Congress and consumer protection groups against a proposed FDA rule governing when a manufacturer can make a labeling change without prior approval from FDA, but the device industry has its own reasons

More from Archive

More from Medtech Insight